Joern Pollex/Getty Images A controversial blood-transfusion startup called Ambrosia was offering to fill a person’s veins with the blood of young people for $8,000, despite little to no hard evidence that the procedure has any health benefits. The company has now shut down, according to emails sent by the founder and viewed by Business Insider. […]